W. Yao

发表论文 53 篇 · 总被引 1659 次 · h-index 19

代表论文

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (2022 · The Lancet Oncology · 被引 353)
Camrelizumab plus carboplatin and paclitaxel as first-line treatment for advanced squamous non-small-cell lung cancer (CameL-sq): a phase 3 trial. (2021 · Journal of Thoracic Oncology · 被引 237)
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial. (2022 · The Lancet Oncology · 被引 187)
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study. (2024 · The Lancet Oncology · 被引 56)
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial (2022 · Molecular Cancer · 被引 44)
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer (2023 · British Journal of Cancer · 被引 38)